Top Markets
#1 Official Trump Official Trump +51.60%
#2 Mubarak Mubarak +28.48%
#3 Melania Meme Melania Meme +26.88%
#4 Movement Movement +26.70%
#5 Zama Zama +26.06%
#6 EXOD EXOD +22.08%
#7 Pearl Pearl +21.29%
#8 Wrapped POL Wrapped POL +18.85%
#9 POL (ex-MATIC) POL (ex-MATIC) +18.51%
#10 Wrapped STX (Velar) Wrapped STX (Velar) +16.86%
Coin of the day
Official Trump Official Trump
Settings
Language
ENGLISH
Currency
USD
Theme
Citius Oncology, Inc. Citius Oncology, Inc.

Citius Oncology, Inc.

CTOR
Rank in Stocks #23802
Citius Oncology, Inc. concentrates on advancing innovative, targeted... Citius Oncology, Inc. concentrates on advancing innovative, targeted therapeutic solutions for various cancer types. A key aspect of its pipeline includes the development of LYMPHIR, an investigational orphan drug intended to treat adults battling cutaneous T-cell lymphoma that has either relapsed or is unresponsive to existing therapies. The firm's main offices are situated in New York, New York. Citius Oncology, Inc. functions as a division of its parent company, Citius Pharmaceuticals, Inc.
Share Price
$0.7426
Last synced: 2026-08-21
Market Cap
$69.05M
Change (1 day)
-2.17%
Change (1 year)
-57.57%
Country
US
Trade Citius Oncology, Inc. (CTOR)

Category

Healthcare
Stock split history for Citius Oncology, Inc. (CTOR)
Citius Oncology, Inc. stock (symbol: CTOR) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 22, 2026.
One CTOR share bought prior to Aug 22, 2026 would equal to 0 CTOR shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 4 x15
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 7 x432
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 0 -
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 2 x10000
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 7 x226
US